University Medical Center Hamburg Eppendorf, Department of Psychiatry and Psychotherapy, Martinistrasse 52, 20246 Hamburg, Germany.
Neuropharmacology. 2013 Sep;72:179-86. doi: 10.1016/j.neuropharm.2013.04.039. Epub 2013 May 3.
Antipsychotic medication represents the first-line treatment for schizophrenia. While it is undisputed that antipsychotics ameliorate positive symptoms, the exact cognitive and emotional pathways through which the effect is exerted has remained unclear. The present study investigated the subjective effects of antipsychotics across various domains of cognition and emotion in both patients with psychotic symptoms and patients with other psychiatric diagnoses. A total of 69 patients with a probable history of psychosis or psychotic symptoms and 26 patients with psychiatric diagnoses other than psychosis participated in a survey conducted over the Internet. Multiple control measures aimed to secure response validity. All patients were currently or had previously been treated with antipsychotic agents. A questionnaire comprising 49 items and measuring possible effects of antipsychotics on cognition and emotion was administered. For 30 out of 49 items a clear response pattern emerged, which was similar for patients with psychotic disorders and patients with other diagnoses. Factor analysis of these items revealed three main effects of antipsychotic medication related to doubt and self-doubt, cognitive and emotional numbing, and social withdrawal. Antipsychotic treatment appears to be connected to a number of negative subjective effects on cognition and emotion. Further studies are warranted to assess how these effects impact on the patients' subjective well-being and quality of life, as well as their association with antipsychotic efficacy on one hand, and adherence rates on the other. Induction of doubt and dampening of emotion may be one reason why antipsychotics work and at the same time offer an explanation why they are experienced as rather unpleasant and are eventually discontinued by many patients.
抗精神病药物是精神分裂症的一线治疗药物。虽然抗精神病药改善阳性症状是无可争议的,但确切的认知和情感途径仍不清楚。本研究调查了精神病症状患者和其他精神诊断患者在认知和情绪各个领域的抗精神病药物的主观效应。共有 69 名可能有精神病史或精神病症状的患者和 26 名有非精神病诊断的患者参加了一项在线调查。多项控制措施旨在确保响应的有效性。所有患者目前或以前都曾接受过抗精神病药物治疗。采用包含 49 个项目的问卷,测量抗精神病药物对认知和情绪的可能影响。对于 49 个项目中的 30 个,出现了清晰的反应模式,这对于精神病患者和其他诊断患者是相似的。对这些项目进行因子分析,揭示了抗精神病药物治疗的三个主要影响,与怀疑和自我怀疑、认知和情感麻木以及社会退缩有关。抗精神病药物治疗似乎与认知和情绪方面的许多负面主观效应有关。需要进一步研究来评估这些影响如何影响患者的主观幸福感和生活质量,以及它们与抗精神病药物疗效的关系,以及与药物的顺应性的关系。怀疑的产生和情绪的抑制可能是抗精神病药物起作用的原因之一,同时也解释了为什么它们被体验为相当不愉快,并且最终被许多患者停止使用。